Join
Live feed
·
INSIDERFilingvia Quantisnow
Grace Therapeutics Inc. logo

Large owner Opaleye Management Inc. bought $24,206 worth of shares (11,608 units at $2.09) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
GRCE· Grace Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GRCE (Grace Therapeutics Inc.) and more on Quantisnow.